111 results
Treatment options for patients with Chronic Symptomatic Systolic Heart Failure

#sCHF #CongestiveHeartFailure #Systolic #HFrEF #Algorithm #Management #Cardiology
Treatment options ... Heart Failure #sCHF ... HFrEF #Algorithm #Management ... #Cardiology #ivabradine ... #Medications
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A
Guideline for the Management ... #HeartFailure #Management ... #CHF #guideline ... #ACCAHA2017 #cardiology ... #treatment #algorithm
Immediate Treatment for Myocardial infraction
#management #pharmacology #medications #treatment #cardiology #mnemonic
Immediate Treatment ... Myocardial infraction #management ... #pharmacology #medications ... #treatment #cardiology
Shock - Differential Diagnosis Framework
 - MAP <65. SBP <90, drop in SBP > 40
 -
Shock - Differential ... Failure, Toxins/Medications ... Decompensated CHF ... Abdominal compartment syndrome ... #management
Algorithm for screening/diagnosis and treatment/follow‐up of iron deficiency in patients with chronic heart failure. Hb, haemoglobin;
/diagnosis and treatment ... Iron #Deficiency #Management ... Diagnosis #HFrEF #sCHF ... #HeartFailure #Cardiology ... #Indications #Treatment
Short Stature - Differential Diagnosis Algorithm
Normal Variant, Normal Puberty Onset (BA = CA)
 • Familial Short
Short Stature - Differential ... Panhypopituitarism Treatment ... CRF) • Infection ... Cystic Fibrosis, CHF ... #ShortStature #Differential
Diagnostic Algorithm for Treatment of Iron Deficiency in Patients With Heart Failure 

Consensus Recommendations 

#Iron #Deficiency
Algorithm for Treatment ... Iron #Deficiency #Management ... Algorithm #HFrEF #sCHF ... #HeartFailure #Indications ... #Treatment
Hyperviscosity Syndrome - Causes and Treatment

 - Waldenstrom macroglobulinemia (most common) / Plasmapheresis 
 - Multiple
Hyperviscosity Syndrome ... - Causes and Treatment ... Phlebotomy - MH/CCF ... #Causes #Differential ... #Management
Medications associated with neuroleptic malignant syndrome

First-generation and second-generation antipsychotics are dopamine receptor antagonists, which produce a
Medications associated ... neuroleptic malignant syndrome ... after years of treatment ... #Diagnosis #Differential ... #Medications #Drugs
STAGES of CHF (A, B, C, D), however, describe the severity of structural abnormalities that impair
STAGES of CHF (A ... sometimes advanced treatment ... Treatments may include ... #Management #Cardiology ... #CHF #Congestive